Heron Therapeutics, Inc.
NASDAQ: HRTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Craig Alexander Collard
- Employees
- 122
- Headquarters
- Cary, United States
- IPO year
- 1987
- Market cap
- $68.4M
- Website
- https://www.herontx.com
Loading HRTX…
Loading profile data…Frequently asked questions about HRTX
What does Heron Therapeutics, Inc. (HRTX) do?
Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concen...
Where does HRTX trade?
Heron Therapeutics, Inc. (HRTX) trades on the NASDAQ Capital Market.
What sector is HRTX in?
Heron Therapeutics, Inc. (HRTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Heron Therapeutics, Inc.?
Craig Alexander Collard is the chief executive officer of Heron Therapeutics, Inc. (HRTX).
Where is Heron Therapeutics, Inc. headquartered?
Heron Therapeutics, Inc. is headquartered in United States.
Does HRTX pay a dividend?
Heron Therapeutics, Inc. (HRTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HRTX go public?
Heron Therapeutics, Inc. (HRTX) completed its initial public offering in 1987.